ClinicalTrials.govpublic full text
Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy
acute leukaemia, chronic leukaemia, myeloma, lymphoma, radioimmunotherapy, transplant, bone marrow transplant (bmt), yttrium, indium, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858001
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.